"With EBR I have no idea. However if some of those competitors are big Pharma related and EBR could cut into their profits, then game on."
Actually EBR's device is complementary to the existing pacemakers, not a competitor.
Charting, page-204
-
- There are more pages in this discussion • 164 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EBR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.01 |
Change
-0.030(2.88%) |
Mkt cap ! $372.8M | |||
| Open | High | Low | Value | Volume |
| $1.03 | $1.04 | $1.01 | $66.24K | 64.85K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 4247 | $1.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.01 | 6000 | 1 |
View Market Depth
| Last trade - 15.10pm 01/11/2024 (20 minute delay) ? |
| EBR (ASX) Chart |